In July 2014, AmSurg Corp. acquired Sheridan Healthcare Inc. from private equity firm Hellman & Friedman LLC for about $2.35 billion in cash and stock in order to enter the outsourced physician services market. Bass, Berry & Sims has represented AmSurg for more than 15 years and served as lead counsel on the transaction. AmSurg’s legal team is led by Healthcare Practice Chair, Jim Jenkins.
Bass, Berry & Sims coordinated and completed healthcare regulatory, corporate, real estate, benefits and labor due diligence, negotiated all related deal documents, and handled the related SEC filings required to be made by AmSurg. The firm also represented AmSurg in its common stock, preferred stock and senior notes offerings as well as entering into a new credit facility. The transaction closed 47 days following execution of definitive agreements.
AmSurg Corp. (NASDAQ: AMSG) acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States.